Universität zu Köln

Christoph, D. C. C., Rizzo, F., Kambartel, K-O., Winke, S., Panse, J., Abdulla, D. S., Scheffler, M., Azeh, I. T., Hoiczyk, M., Turki, A. and Metzenmacher, M. (2020). Docetaxel/nindetanib as efficient treatment option after failure of immune checkpoint inhibition: Real-world evidence. Ann. Oncol., 31. S. S876 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041

Full text not available from this repository.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Christoph, D. C. C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Rizzo, F. UNSPECIFIED UNSPECIFIED UNSPECIFIED Kambartel, K-O. UNSPECIFIED UNSPECIFIED UNSPECIFIED Winke, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Panse, J. UNSPECIFIED UNSPECIFIED UNSPECIFIED Abdulla, D. S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Scheffler, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Azeh, I. T. UNSPECIFIED UNSPECIFIED UNSPECIFIED Hoiczyk, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Turki, A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Metzenmacher, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-320598
DOI:	10.1016/j.annonc.2020.08.1688
Journal or Publication Title:	Ann. Oncol.
Volume:	31
Page Range:	S. S876 - 1
Date:	2020
Publisher:	ELSEVIER
Place of Publication:	AMSTERDAM
ISSN:	1569-8041
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language Oncology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/32059